We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$11.2B
AUM Growth
-$244M
Cap. Flow
-$183M
Cap. Flow %
-1.64%
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Financials 13.17%
3 Healthcare 12.67%
4 Consumer Discretionary 11.48%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMTR
2401
DELISTED
9 Meters Biopharma
NMTR
$110K ﹤0.01%
+4,238
New +$99.9K
TXMD icon
2402
TherapeuticsMD
TXMD
$24.1M
$110K ﹤0.01%
2,972
+1,968
+196% +$87.3K
ARTNA icon
2403
Artesian Resources
ARTNA
$362M
$110K ﹤0.01%
+2,874
New +$110K
DJCO icon
2404
Daily Journal
DJCO
$767M
$110K ﹤0.01%
342
-256
-43% -$83.8K
FNLC icon
2405
First Bancorp
FNLC
$402M
$110K ﹤0.01%
+3,758
New +$109K
CCB icon
2406
Coastal Financial
CCB
$754M
$110K ﹤0.01%
+3,437
New +$102K
INTA icon
2407
Intapp
INTA
$3.05B
$109K ﹤0.01%
+4,245
New +$138K
STGW icon
2408
Stagwell
STGW
$2.29B
$109K ﹤0.01%
14,254
-9,978
-41% -$66.6K
RUSHB icon
2409
Rush Enterprises Class B
RUSHB
$9.18B
$109K ﹤0.01%
+3,582
New +$101K
VIEW
2410
DELISTED
View, Inc. Class A Common Stock
VIEW
$109K ﹤0.01%
335
-248
-43% -$87.1K
VSTM icon
2411
Verastem
VSTM
$629M
$109K ﹤0.01%
2,940
-2,534
-46% -$93.1K
HGEN
2412
DELISTED
HUMANIGEN, INC.
HGEN
$108K ﹤0.01%
18,193
SGHT icon
2413
Sight Sciences
SGHT
$456M
$108K ﹤0.01%
+4,737
New +$156K
HBCP icon
2414
Home Bancorp
HBCP
$567M
$107K ﹤0.01%
+2,776
New +$103K
KALV
2415
DELISTED
KalVista Pharmaceuticals
KALV
$107K ﹤0.01%
6,130
QMCO icon
2416
Quantum Corp
QMCO
$864M
$107K ﹤0.01%
+1,033
New +$122K
EGIO
2417
DELISTED
Edgio, Inc. Common Stock
EGIO
$107K ﹤0.01%
1,123
+813
+262% +$85.7K
PASG icon
2418
Passage Bio
PASG
$14.8M
$107K ﹤0.01%
537
CCRD
2419
DELISTED
CoreCard
CCRD
$106K ﹤0.01%
+2,617
New +$93.2K
EBF icon
2420
Ennis
EBF
$556M
$106K ﹤0.01%
5,631
-4,487
-44% -$88K
RPT
2421
Rithm Property Trust
RPT
$99.9M
$106K ﹤0.01%
+1,310
New +$105K
GLUE icon
2422
Monte Rosa Therapeutics
GLUE
$1.36B
$106K ﹤0.01%
+4,756
New +$136K
INBK icon
2423
First Internet Bancorp
INBK
$255M
$106K ﹤0.01%
+3,385
New +$102K
AKUS
2424
DELISTED
Akouos Inc
AKUS
$105K ﹤0.01%
+9,074
New +$109K
UFI icon
2425
UNIFI
UFI
$127M
$104K ﹤0.01%
+4,765
New +$108K

Similar funds

MetLife Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
  • MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
  • MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
  • MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
  • MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.